Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.17955243 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- <p>Background: Meningococcal disease, caused by Neisseria meningitidis, remains a serious global health threat due to its rapid onset and high mortality. While effective conjugate vaccines exist, vaccination policies vary significantly worldwide based on disease epidemiology and resource allocation.</p> <p>Objective: This study aims to conduct a comparative analysis of global vaccination guidelines (WHO, CDC) versus the current national immunization policies of India regarding meningococcal disease.</p> <p>Methods: A descriptive review was conducted analyzing official policy documents from the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and India’s Ministry of Health and Family Welfare (MoHFW) published between 2015 and 2023.</p> <p>Results: Global guidelines recommend routine immunization of adolescents and high-risk groups with quadrivalent meningococcal conjugate vaccines (MenACWY). In contrast, India’s national policy does not include meningococcal vaccination in the Universal Immunization Programme (UIP). In India, vaccination is reactive (outbreak-based) or targeted at specific travelers (Hajj pilgrims), with limited proactive use in the general population.</p> <p>Conclusion: A significant disparity exists between proactive global standards and India’s reactive national strategy. While currently justified by epidemiological data, this gap suggests a need for continuous surveillance to determine if routine vaccination should be introduced</p> <p> </p>